Tregs, which are usually known for maintaining immune homeostasis by suppressing the immune system’s self-reactive immune responses, are the main tumor-promoting CD4+ helper T-cell subpopulation [4], and are associated with poor clinical prognosis in patients with NSCLC [5]. The gene discussed is CD4; the disease is neoplasm.